Table 2.

Top 10 publications with the most citations in retinoblastoma research.

Title	Corresponding authors	Journal	Publication year	Total citations
Inactivation of the p53 pathway in retinoblastoma	Michael A. Dyer	Nature	2006	427
A novel retinoblastoma therapy from genomic and epigenetic analyses	Michael A. Dyer James R. Downing Richard K. Wilson	Nature	2012	289
Retinoblastoma	Gallie, BL	Lancet	2012	288
The international classification of retinoblastoma predicts chemoreduction success	Shields, CL	Ophthalmology	2006	279
A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma - Initial results	Abramson, DH	Ophthalmology	2008	259
Intra-arterial Chemotherapy for the Management of Retinoblastoma Four-Year Experience	Gobin, YP	Archives of Ophthalmology	2011	239
Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma	Bremner, R	Cancer Cell	2004	200
Lifetime risks of common cancers among retinoblastoma survivors	Peto, J	Jnci-Journal of the National Cancer Institute	2004	174
Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications	Munier, FL	British Journal of Ophthalmology	2012	173
Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy	Shields, CL	Current Opinion in Ophthalmology	2010	169